Drivers of cost differences between US breast cancer survivors with or without lymphedema

PURPOSE: Breast cancer–related lymphedema is an adverse effect of breast cancer surgery affecting nearly 30% of US breast cancer survivors (BCS). Our previous analysis showed that, even 12 years after cancer treatment, out-of-pocket healthcare costs for BCS with lymphedema remained higher than for B...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Lorraine T., Ransome, Yusuf, Frasso-Jaramillo, Livia, Moss, Shadiya L., Zhang, Yuehan, Ashing, Kimlin, Denis, Gerald V., Frick, Kevin D., Visvanathan, Kala, Schmitz, Kathryn H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828620/
https://www.ncbi.nlm.nih.gov/pubmed/31446591
http://dx.doi.org/10.1007/s11764-019-00799-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828620/
https://www.ncbi.nlm.nih.gov/pubmed/31446591
http://dx.doi.org/10.1007/s11764-019-00799-1

Ejemplares similares